Results
|
|
41.
|
|
|
|
42.
|
|
|
|
43.
|
|
|
|
44.
|
|
|
|
45.
|
|
|
|
46.
|
|
|
|
47.
|
|
|
|
48.
|
|
|
|
49.
|
|
|
|
50.
|
|
|
|
51.
|
|
|
|
52.
|
|
|
|
53.
|
Renin inhibitors. Statine-containing tetrapeptides with varied hydrophobic carboxy termini. [electronic resource] by
- Bock, M G
- DiPardo, R M
- Evans, B E
- Rittle, K E
- Boger, J
- Poe, M
- LaMont, B I
- Lynch, R J
- Ulm, E H
- Vlasuk, G P
Producer: 19871106
In:
Journal of medicinal chemistry vol. 30
Availability: No items available.
|
|
|
54.
|
A uniquely potent renin inhibitor and its unanticipated plasma binding component. [electronic resource] by
- Evans, B E
- Rittle, K E
- Bock, M G
- Bennett, C D
- DiPardo, R M
- Boger, J
- Poe, M
- Ulm, E H
- LaMont, B I
- Blaine, E H
Producer: 19860116
In:
Journal of medicinal chemistry vol. 28
Availability: No items available.
|
|
|
55.
|
1-((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo [2.2.1]-heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperaz ine (L-368,899): an orally bioavailable, non-peptide oxytocin antagonist with potential utility for managing preterm labor. [electronic resource] by
- Williams, P D
- Anderson, P S
- Ball, R G
- Bock, M G
- Carroll, L
- Chiu, S H
- Clineschmidt, B V
- Culberson, J C
- Erb, J M
- Evans, B E
Producer: 19940412
In:
Journal of medicinal chemistry vol. 37
Availability: No items available.
|
|
|
56.
|
Progress in the development of oxytocin antagonists for use in preterm labor. [electronic resource] by
- Pettibone, D J
- Guidotti, M
- Harrell, C M
- Jasper, J R
- Lis, E V
- O'Brien, J A
- Reiss, D R
- Woyden, C J
- Bock, M G
- Evans, B E
Producer: 19960919
In:
Advances in experimental medicine and biology vol. 395
Availability: No items available.
|
|
|
57.
|
Renin inhibitors containing hydrophilic groups. Tetrapeptides with enhanced aqueous solubility and nanomolar potency. [electronic resource] by
- Bock, M G
- DiPardo, R M
- Evans, B E
- Freidinger, R M
- Rittle, K E
- Payne, L S
- Boger, J
- Whitter, W L
- LaMont, B I
- Ulm, E H
Producer: 19881118
In:
Journal of medicinal chemistry vol. 31
Availability: No items available.
|
|
|
58.
|
Cholecystokinin antagonists. Synthesis of asperlicin analogues with improved potency and water solubility. [electronic resource] by
- Bock, M G
- DiPardo, R M
- Rittle, K E
- Evans, B E
- Freidinger, R M
- Veber, D F
- Chang, R S
- Chen, T B
- Keegan, M E
- Lotti, V J
Producer: 19861119
In:
Journal of medicinal chemistry vol. 29
Availability: No items available.
|
|
|
59.
|
Cholecystokinin-A receptor ligands based on the kappa-opioid agonist tifluadom. [electronic resource] by
- Bock, M G
- DiPardo, R M
- Evans, B E
- Rittle, K E
- Whitter, W L
- Veber, D F
- Freidinger, R M
- Chang, R S
- Chen, T B
- Lotti, V J
Producer: 19900222
In:
Journal of medicinal chemistry vol. 33
Availability: No items available.
|
|
|
60.
|
Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. [electronic resource] by
- Evans, B E
- Rittle, K E
- Bock, M G
- DiPardo, R M
- Freidinger, R M
- Whitter, W L
- Lundell, G F
- Veber, D F
- Anderson, P S
- Chang, R S
Producer: 19890112
In:
Journal of medicinal chemistry vol. 31
Availability: No items available.
|